BioNexus Gene Lab Corp Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BioNexus Gene Lab Corp quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • BioNexus Gene Lab Corp Depreciation for the quarter ending March 31, 2024 was $20.1K, a 3.63% decline year-over-year.
  • BioNexus Gene Lab Corp annual Depreciation for 2023 was $83.3K, a 8.94% decline from 2022.
  • BioNexus Gene Lab Corp annual Depreciation for 2022 was $91.4K, a 0.16% increase from 2021.
  • BioNexus Gene Lab Corp annual Depreciation for 2021 was $91.3K, a 0.55% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $20.1K -$759 -3.63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $20.9K -$1.41K -6.32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $22.3K +$11.7K +110% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $10.6K +$344 +3.35% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $10.3K -$284 -2.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-18
Q1 2019 $10.6K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.